Explore how genetic differences between Uzbek and Japanese populations affect cancer drug metabolism and personalized treatment approaches.
Discover how pharmacogenetic testing is transforming depression treatment by using genetic profiles to guide medication selection, improving outcomes and reducing costs.
Explore how GSTP1 genetic polymorphism affects toxicity in platinum-based chemotherapy and the future of personalized cancer treatment.
Exploring how genetic polymorphisms in metabolic enzymes influence anti-tuberculosis drug-induced hepatotoxicity and the future of personalized medicine.
Discover how genetic variations in enzymes like CYP3A5 and CYP2D6 affect tamoxifen response in breast cancer patients and the promise of personalized medicine.
Exploring how TPMT gene variants affect enzyme activity and drug metabolism through different molecular mechanisms.
Discover how CES1 and SLC6A2 genetic variants predict methylphenidate response in autism spectrum disorders with ADHD symptoms.